Comirnaty Vaccine Files - Part 2

Pharmacokinetics

Pharmacokinetic (PK) studies are essential for understanding how any pharmaceutical intervention works in the body. They provide insight into how the human body responds to inhaled, swallowed, or injected substances. When Comirnaty was registered, the PK evidence was derived from studies conducted on rats rather than humans.

What makes up the Comirnaty Vaccine?

As reported by the MSF, Comirnaty consists of lipid nanoparticles (LNP) and modified messenger RNA (modmRNA). It also contains several other ingredients (see Table 9, page 18 of the report).

Lipid nano particles (LNPs)

Lipid nanoparticles (LNPs) are small fatty structures designed to protect the core component, modified mRNA (modRNA), from our immune system while delivering it to its target location. Think of LNPs as the packaging that safeguards your parcels.

LNPs encapsulate the modified mRNA (modmRNA) that encodes a version of the spike glycoprotein from the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). When inje…